NL
DE
15 July 2019
The project 'Off-the-shelf umbilical cord blood derived natural killer cells for cancer immunotherapy' focuses on natural killer cell therapry. Natural killer cell therapy is an interesting relatively new immunotherapy-showing efficacy with little side effects. Currently, the personalized nature and long culture times result in high cost and difficult logistics. This project aims to generate a cryopreserved, off-the-shelve product, allowing immediate application at greatly reduced cost.
The grant is part of the Dutch National Research Agenda - Idea Generator (Nationale Wetenschapsagenda - Ideeëngenerator) and will be used to further investigate the idea for one year.
More information can be found on the NWO website.
The project 'Off-the-shelf umbilical cord blood derived natural killer cells for cancer immunotherapy' focuses on natural killer cell therapry. Natural killer cell therapy is an interesting relatively new immunotherapy-showing efficacy with little side effects. Currently, the personalized nature and long culture times result in high cost and difficult logistics. This project aims to generate a cryopreserved, off-the-shelve product, allowing immediate application at greatly reduced cost.
The grant is part of the Dutch National Research Agenda - Idea Generator (Nationale Wetenschapsagenda - Ideeëngenerator) and will be used to further investigate the idea for one year.
More information can be found on the NWO website.
Related news items
T cell immunity is directed by tetraspanin CD53
5 July 2022 T cells are immune cells that are key for the defense against pathogens and cancer. T cells depend on the membrane protein CD45 to initiate T cell receptor signaling, but how CD45 is controlled at the molecular level is poorly understood. read more
A single protein complex balances the very first lineage decision of cells in human: towards foetus or placenta
21 June 2022 The international group of researchers spearheaded by Dick Zijlmans and Hendrik Marks together with colleagues from KU Leuven, examined which proteins are associated with the chromatin and how this affects gene transcription. read more
Dutch Society of Clinical Chemistry Science & Innovation Award for the team of Hans Jacobs
14 June 2022 The team of Hans Jacobs pioneers on the development of personalized diagnostics to measure minimal residual disease in patients with multiple myeloma. read more
European grants for groundbreaking Radboudumc research Professors Roshan Cools and Peter Friedl receive ERC Advanced Grant
26 April 2022The European Research Council (ERC) is awarding grants to Roshan Cools and Peter Friedl, both professors at Radboudumc. While Cools will investigate how brains control behaviour in (stressful) situations, Friedl will work on developing a new cancer therapy.
read more
Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation published in Cellular and Molecular Life Sciences
20 April 2022 Lisa Huis in ‘t Veld, Nataschja Ho and colleagues from the team of Gosse Adema published in Cellular and Molecular Life Sciences that Saponin-based adjuvant-induced dendritic cell cross-presentation is dependent on PERK activation. read more
